CSBR

Champions Oncology, Inc.

6.81 USD
+1.24 (+22.26%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Champions Oncology, Inc. stock is up 13.69% since 30 days ago. The next earnings date is Mar 13, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 8 February’s closed higher than January.

About Champions Oncology, Inc.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company markets its products through internet, word of mouth, and sales force.